Vipin Kumar Chaturvedi
Chief Tech/Sci/R&D Officer at GRI BIO, INC.
Net worth: 353 $ as of 2024-04-29
Profile
Vipin Kumar Chaturvedi is the founder.
He founded Simomics Ltd.
in 2015, where he held the title of Non-Executive Director from 2015 to 2022.
Dr. Chaturvedi's current job is as the Chief Scientific Officer at GRI Bio, Inc. since 2023.
Dr. Chaturvedi's former job was as the Chief Scientific Officer at Vallon Pharmaceuticals, Inc. He also worked as a Professor at the University of California San Diego from 2022 to 2023.
Dr. Chaturvedi obtained a doctorate degree from the Indian Institute of Science and an undergraduate degree from Chhatrapati Shahu Ji Maharaj University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GRI BIO, INC.
0.02% | 2023-04-20 | 820 ( 0.02% ) | 353 $ | 2024-04-29 |
Vipin Kumar Chaturvedi active positions
| Companies | Position | Start |
|---|---|---|
| GRI BIO, INC. | Chief Tech/Sci/R&D Officer | 2023-03-31 |
Former positions of Vipin Kumar Chaturvedi
| Companies | Position | End |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 2023-02-28 |
Simomics Ltd.
 Simomics Ltd. Packaged SoftwareTechnology Services Simomics Ltd. is a British company that develops integrated cloud-deployed evidencing tools. | Founder | 2022-06-30 |
| GRI BIOPAR | Chief Tech/Sci/R&D Officer | - |
Training of Vipin Kumar Chaturvedi
| Indian Institute of Science | Doctorate Degree |
| Chhatrapati Shahu Ji Maharaj University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GRI BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Simomics Ltd.
Simomics Ltd. Packaged SoftwareTechnology Services Simomics Ltd. is a British company that develops integrated cloud-deployed evidencing tools. | Technology Services |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Vipin Kumar Chaturvedi
